Innate Pharma SA
F:IDD
Innate Pharma SA
F:IDD
Kurs:
1,532
EUR
1,06%
Markt geschlossen
Marktkap.:
€124,02 Mio.
Notiz hinzufügen
Kursziel hinzufügen
Gedanken festhalten und ein Kursziel setzen
Legen Sie fest, zu welchem Kurs Sie kaufen würden. Wir helfen Ihnen, bereit zu bleiben.
Basierend auf
Sicherheitsmarge
0%
10%
20%
30%
40%
50%
Ihr Kursziel
Verknüpft mit
aktuellem Kurs
· In Kaufzone
Lädt
Notiz verknüpft
Wählen Sie die Aktie, die Sie mit einem Kursziel beobachten möchten
Zuletzt angesehen
|
Innate Pharma SA
F:IDD
|
FR |
Cashflow-Rechnung
Cashflow-Rechnung
Innate Pharma SA
Innate Pharma SA
Währung: EUR
| Dec-2007 | Jun-2008 | Dec-2008 | Jun-2009 | Dec-2009 | Jun-2010 | Dec-2010 | Jun-2011 | Dec-2011 | Jun-2012 | Dec-2012 | Jun-2013 | Dec-2013 | Jun-2014 | Dec-2014 | Jun-2015 | Dec-2015 | Jun-2016 | Dec-2016 | Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operativer Cashflow | ||||||||||||||||||||||||||||||||||||||
| Nettogewinn |
(9)
|
(8)
|
(10)
|
(16)
|
(15)
|
(13)
|
(14)
|
(12)
|
(7)
|
(4)
|
(3)
|
(4)
|
(3)
|
(10)
|
(20)
|
(19)
|
(7)
|
(2)
|
13
|
(8)
|
(48)
|
(40)
|
3
|
31
|
(21)
|
(44)
|
(64)
|
(77)
|
(53)
|
(23)
|
(58)
|
(63)
|
(8)
|
(34)
|
(49)
|
(46)
|
(49)
|
|
| Abschreibungen |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
3
|
3
|
3
|
3
|
4
|
5
|
7
|
12
|
17
|
16
|
57
|
52
|
5
|
4
|
45
|
47
|
5
|
3
|
2
|
2
|
1
|
|
| Aktienbasierte Vergütung |
1
|
2
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
10
|
0
|
3
|
0
|
4
|
0
|
2
|
3
|
3
|
4
|
4
|
3
|
4
|
5
|
4
|
4
|
3
|
|
| Sonstige nicht zahlungswirksame Posten |
1
|
2
|
2
|
3
|
1
|
(0)
|
(0)
|
(1)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
6
|
13
|
5
|
4
|
2
|
(1)
|
3
|
4
|
4
|
(1)
|
0
|
6
|
4
|
2
|
0
|
1
|
5
|
6
|
|
| Gezahlte Steuern |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gezahlte Zinsen |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
| Veränderung des Working Capital |
(2)
|
(5)
|
(8)
|
6
|
7
|
(5)
|
(1)
|
3
|
19
|
13
|
(9)
|
(10)
|
(9)
|
(4)
|
(1)
|
215
|
205
|
(31)
|
(51)
|
(40)
|
(17)
|
(29)
|
(47)
|
15
|
40
|
(58)
|
(49)
|
(4)
|
(10)
|
(8)
|
(13)
|
(21)
|
(32)
|
14
|
39
|
(2)
|
(11)
|
|
| Cashflow aus operativer Tätigkeit |
(9)
N/A
|
(11)
-15%
|
(15)
-37%
|
(6)
+56%
|
(6)
+8%
|
(18)
-202%
|
(13)
+25%
|
(8)
+40%
|
13
N/A
|
11
-19%
|
(11)
N/A
|
(12)
-17%
|
(11)
+11%
|
(12)
-7%
|
(18)
-54%
|
199
N/A
|
202
+1%
|
(29)
N/A
|
(37)
-27%
|
(38)
-3%
|
(48)
-27%
|
(59)
-23%
|
(33)
+45%
|
61
N/A
|
35
-43%
|
(83)
N/A
|
(52)
+37%
|
(25)
+52%
|
(58)
-135%
|
(26)
+55%
|
(19)
+27%
|
(31)
-64%
|
(33)
-4%
|
(19)
+42%
|
(7)
+64%
|
(41)
-496%
|
(53)
-28%
|
|
| Investitions-Cashflow | ||||||||||||||||||||||||||||||||||||||
| Investitionsausgaben |
(1)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(0)
|
(2)
|
(2)
|
(0)
|
(1)
|
(9)
|
(9)
|
(3)
|
(6)
|
(6)
|
(1)
|
(65)
|
(65)
|
(10)
|
(11)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(0)
|
(0)
|
(0)
|
|
| Sonstige Posten |
6
|
8
|
24
|
18
|
20
|
0
|
0
|
3
|
3
|
1
|
(2)
|
(1)
|
(1)
|
(3)
|
(1)
|
1
|
(115)
|
(79)
|
70
|
33
|
(23)
|
(8)
|
26
|
13
|
3
|
(2)
|
(2)
|
0
|
0
|
0
|
3
|
3
|
23
|
24
|
10
|
15
|
7
|
|
| Cashflow aus Investitionstätigkeit |
5
N/A
|
6
+22%
|
23
+269%
|
18
-21%
|
19
+7%
|
19
N/A
|
(0)
N/A
|
2
N/A
|
2
+4%
|
(1)
N/A
|
(3)
-467%
|
(2)
+44%
|
(1)
+47%
|
(5)
-420%
|
(4)
+26%
|
1
N/A
|
(116)
N/A
|
(88)
+24%
|
61
N/A
|
30
-51%
|
(29)
N/A
|
(13)
+56%
|
24
N/A
|
(52)
N/A
|
(62)
-19%
|
(12)
+80%
|
(13)
-8%
|
(2)
+89%
|
(1)
+39%
|
(1)
-16%
|
2
N/A
|
2
+8%
|
21
+920%
|
22
+8%
|
9
-59%
|
15
+66%
|
7
-52%
|
|
| Finanzierungs-Cashflow | ||||||||||||||||||||||||||||||||||||||
| Nettoausgabe von Stammaktien |
0
|
0
|
0
|
0
|
23
|
23
|
(0)
|
(0)
|
0
|
0
|
0
|
1
|
20
|
68
|
49
|
1
|
4
|
3
|
0
|
1
|
0
|
0
|
63
|
63
|
66
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
3
|
18
|
15
|
|
| Nettoaufnahme von Schulden |
0
|
1
|
1
|
(1)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(1)
|
(1)
|
0
|
(1)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
1
|
1
|
(1)
|
(1)
|
12
|
12
|
(1)
|
(1)
|
27
|
27
|
(2)
|
(3)
|
(2)
|
(5)
|
(9)
|
(9)
|
(9)
|
|
| Sonstiges |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
1
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cashflow aus Finanzierungstätigkeit |
1
N/A
|
1
N/A
|
1
N/A
|
(1)
N/A
|
23
N/A
|
22
-1%
|
(1)
N/A
|
(1)
N/A
|
(1)
+22%
|
(2)
-171%
|
(2)
-11%
|
(1)
+67%
|
20
N/A
|
68
+245%
|
48
-29%
|
1
-99%
|
3
+333%
|
2
-41%
|
(1)
N/A
|
(1)
-16%
|
1
N/A
|
1
-45%
|
61
+12.144%
|
61
0%
|
78
+27%
|
77
-1%
|
(1)
N/A
|
(1)
-2%
|
27
N/A
|
27
+1%
|
(2)
N/A
|
(2)
-16%
|
(2)
+7%
|
(5)
-157%
|
(6)
-19%
|
9
N/A
|
6
-31%
|
|
| Veränderung der Zahlungsmittel | ||||||||||||||||||||||||||||||||||||||
| Effekt von Wechselkursänderungen |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
(0)
|
(1)
|
(0)
|
0
|
0
|
(0)
|
(1)
|
1
|
1
|
|
| Nettoveränderung der Zahlungsmittel |
(4)
N/A
|
(4)
-8%
|
8
N/A
|
10
+24%
|
36
+242%
|
24
-34%
|
(15)
N/A
|
(7)
+54%
|
15
N/A
|
8
-46%
|
(16)
N/A
|
(15)
+7%
|
8
N/A
|
51
+562%
|
26
-49%
|
201
+675%
|
89
-56%
|
(115)
N/A
|
23
N/A
|
(9)
N/A
|
(77)
-770%
|
(71)
+7%
|
53
N/A
|
70
+32%
|
51
-28%
|
(18)
N/A
|
(66)
-271%
|
(28)
+58%
|
(33)
-20%
|
(1)
+97%
|
(20)
-1.794%
|
(31)
-59%
|
(14)
+56%
|
(2)
+86%
|
(4)
-114%
|
(16)
-287%
|
(38)
-135%
|
|
| Free Cashflow | ||||||||||||||||||||||||||||||||||||||
| Free Cashflow |
(11)
N/A
|
(12)
-16%
|
(17)
-35%
|
(7)
+58%
|
(6)
+7%
|
(18)
-186%
|
(14)
+25%
|
(9)
+38%
|
13
N/A
|
10
-25%
|
(12)
N/A
|
(13)
-10%
|
(11)
+12%
|
(14)
-25%
|
(20)
-44%
|
199
N/A
|
201
+1%
|
(38)
N/A
|
(46)
-22%
|
(41)
+12%
|
(54)
-33%
|
(64)
-19%
|
(34)
+47%
|
(4)
+88%
|
(30)
-638%
|
(93)
-206%
|
(63)
+32%
|
(27)
+58%
|
(60)
-124%
|
(27)
+54%
|
(20)
+26%
|
(32)
-60%
|
(35)
-8%
|
(21)
+39%
|
(7)
+66%
|
(41)
-466%
|
(53)
-28%
|
|
Wechseln zu:
Wechseln zu:
Auch interessant
Other Innate Pharma SA listings:
Mehr entdecken
